Role of human epidermal growth factor receptor 2 in gastric cancer: Biological and pharmacological aspects

Por Jørgensen, Jan Trøst
Publicado em 2014

Drug-Diagnostics Co-Development in Oncology

Por Jørgensen, Jan Trøst
Publicado em 2014

HER2 as a Prognostic Marker in Gastric Cancer - A Systematic Analysis of Data from the Literature

Por Jørgensen, Jan Trøst, Hersom, Maria
Publicado em 2012

Companion Diagnostics for Targeted Cancer Drugs – Clinical and Regulatory Aspects

Por Olsen, Dana, Jørgensen, Jan Trøst
Publicado em 2014

Companion diagnostics—a tool to improve pharmacotherapy

Por Jørgensen, Jan Trøst, Hersom, Maria
Publicado no Ann Transl Med (2016)

Companion and complementary diagnostics for first-line immune checkpoint inhibitor treatment in non-small cell lung cancer

Por Jørgensen, Jan Trøst, Nielsen, Karsten Bork
Publicado no Transl Lung Cancer Res (2018)

Gene Signal Distribution and HER2 Amplification in Gastroesophageal Cancer

Por Jørgensen, Jan Trøst, Nielsen, Karsten Bork, Kjærsgaard, Gitte, Jepsen, Anna, Mollerup, Jens
Publicado no J Cancer (2017)

Detection of MET amplification in gastroesophageal tumor specimens using IQFISH

Por Jørgensen, Jan Trøst, Nielsen, Karsten Bork, Mollerup, Jens, Jepsen, Anna, Go, Ning
Publicado no Ann Transl Med (2017)

Roles of MET in Cancer Development and Treatment

Publicado em 2023